Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.

Tanager, Kevin S; Yu, Jovian; Chiu, Brian C-H; Carll, Timothy C; Tatarian, Alexandra H; Riedell, Peter; Smith, Sonali; Kline, Justin; Venkataraman, Girish

Tanager, Kevin S; Yu, Jovian; Chiu, Brian C-H; Carll, Timothy C; Tatarian, Alexandra H; Riedell, Peter; Smith, Sonali; Kline, Justin; Venkataraman, Girish.

Affiliation

Tanager KS; The University of Chicago Medicine, Departments of Pathology.
Yu J; Hematology/Oncology.
Chiu BC; Departments, Public Health sciences.
Carll TC; The University of Chicago Medicine, Departments of Pathology.
Tatarian AH; SUNY Upstate College of Medicine, NY.
Riedell P; Hematology/Oncology.
Smith S; Hematology/Oncology.
Kline J; Hematology/Oncology.
Venkataraman G; The University of Chicago Medicine, Departments of Pathology. girish.venkataraman@uchospitals.edu.

Haematologica ; 107(4): 966-969, 2022 04 01.

Article de En | MEDLINE | ID: mdl-34911281

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome B / 5-Méthyl-cytosine Limites: Humans Langue: En Journal: Haematologica Année: 2022 Type de document: Article Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google